A estabilidade genômica é condição essencial à sobrevivência e ao funcionamento dos organismos vivos. No entanto, várias situações podem provocar danos no DNA. Por exemplo, cerca de 104 lesões podem ocorrer no material genético de uma célula de mamífero a cada dia. No intuito de preservar a integridade genômica e contornar os efeitos deletérios destas modificações, uma maquinaria constituída de proteínas especializadas em reconhecer e reparar estes danos foi selecionada ao longo do curso evolutivo. Defeitos em proteínas destas maquinarias causam instabilidade genômica e pode resultar em elevada taxa de mutações e quebras do DNA que resultam em eventos de amplificação gênica, como em células cancerosas. De uma maneira aparentemente contrária ao requerimento de estabilidade genômica como condição primordial para a perpetuação da vida, Leishmania apresenta um genoma notavelmente maleável e explora a amplificação gênica como recurso de sobrevivência. Ainda que a plasticidade genômica em Leishmania seja facilmente demonstrada, nós não conhecemos os mecanismos precisos pelos quais este parasita coordena a ação da maquinaria de detecção de danos no DNA e a consumação dos eventos de amplificação gênica. No intuito de contribuir para a compreensão deste processo, nós identificamos proteínas homólogas do complexo 9-1-1 (Rad9-Hus1-Rad1) em Leishmania major. As proteínas LmHus1 e LmRad9 apresentam marcada divergência estrutural em relação aos seus homólogos em outros eucariotos e nenhuma proteína obviamente homóloga a Rad1 foi identificada neste parasita. Análises filogenéticas indicam que LmHus1 e LmRad9 são relacionadas ao complexos heterotriméricos envolvidos na detecção de danos no DNA. Em acordo com isso, nossos experimentos demonstram que alteração nos níveis destas proteínas interfere na capacidade do parasita em lidar com estresse genotóxico. LmHus1 localiza-se no núcleo, é requerida para o crescimento normal deste parasita e a diminuição de sua expressão compromete mecanismos de controle de ciclo celular e manutenção de telômeros. LmRad9 também localiza-se no núcleo e sua superexpressão causa defeito de crescimento e de resposta ao estresse genotóxico em L. major. Nós observamos que LmHus1 e LmRad9 formam um complexo responsivo ao dano no DNA in vivo, uma forte indicação de que o complexo 9-1-1 tenha sido conservado em L. major. As peculiaridades estruturais destas proteínas sugerem que o complexo 9-1-1 de L. major possua uma arquitetura distinta em comparação aos eucariotos superiores. Em adição a isto, outras proteínas, tais como a LmRpa1, também apresentam uma marcante divergência estrutural. Isso sugere que a via de sinalização de danos no DNA envolvendo o complexo 9-1-1 e Rpa1 de L. major possua mecanismos peculiares de ação. Estas observações podem permitir entender como ocorreu o processo evolutivo da sinalização mediada pelo complexo 9-1-1 nos eucariotos, além de ajudar para o entendimento das bases moleculares de como este parasito conduz os eventos de amplificação gênica. / Genome stability is a essential condition for survival and proper functioning of living organisms. However, a broad range of elements may lead to DNA damage. For instance, about 104 DNA lesions may be inflicted upon any given mammalian cell everyday. In order to maintain the genome integrity and circumvent the deleterious effects of these lesions, a molecular machinery composed of proteins specialized in detecting and repairing DNA damage has been selected in evolution. Defects of the proteins that constitute such machineries may result not only in a high mutation rate, but also in breaks in the DNA structure that can mediate gene amplification as observed in cancer cells. In an apparent opposition to such requirement for stability as an essential condition to life, the protozoan Leishmania presents a highly malleable genome and explores genome amplification as a survival and adaptation tool. Despite of the fact that the Leishmania genome plasticity can be easily demonstrated, the precise mechanisms that coordinate the molecular machineries involved in the detection and signaling of DNA damage, and in the regulation of gene amplification is still largely unknown. In order to contribute to a better understanding of these processes, we identified and studied the Leishmania major proteins that are homologues of those proteins that compose the 9-1-1 complex (Rad9-Hus1-Rad1). The proteins LmHus1 and LmRad9 present a high structural divergence when compared to its homologues from other eukaryotes and no obvious homologue of Rad1 was identified in the parasite genome. Phylogeny analysis indicated that LmHus1 and LmRad9 are closely related to heterotrimeric complexes involved in the detection of DNA damage. In accordance to that, our experiments demonstrated that altered levels of these proteins interfere with the parasite ability to deal with genotoxic stress. Moreover, LmHus1 was localized to the parasite nucleus and is a required protein for normal parasite proliferation. Besides, we showed that decreased levels of LmHus1 compromise cell cycle regulation and the maintenance of telomeres. LmRad9 was also shown to be localized to the cell nucleus and its overexpression led to growth defects and affected the L. major response to genotoxic stress. We also observed that LmHus1 and LmRad9 interact with each other to for a protein complex that is responsive to DNA damage in vivo, which strongly suggested that the 9-1-1 complex was conserved in L. major. The structural peculiarities of these proteins indicate that the possible L. major 9-1-1 complex has a different architecture when compared to the complex found in higher eukaryotes. In addition to that, other proteins, such as LmRpa1, also present a marked structural divergence. Altogether, these findings suggest that the DNA damage signaling pathway involving the 9-1-1 complex and LmRpa1 in L. major, may present a peculiar mode of action. These observations may contribute to a better understanding not only of the evolution of the signaling pathway mediated by the 9-1-1 complex in eukaryotes, but also of the molecular basis of the genome plasticity and the gene amplification phenomenon.

A suplementação de &#946;-caroteno em fumantes e alcoólatras pode promover efeitos indesejáveis, manifestando a característica pró-oxidante deste carotenóide. Sabendo que o fígado é o principal órgão de armazenamento de vitamina A e (&#946;-caroteno, e local de oxidação do etanol, o presente estudo buscou investigar no fígado de ratos, a influência da suplementação de (&#946;-caroteno isolado ou associado ao etanol, sobre o metabolismo celular, danos no DNA, proliferação celular e função da proteína p53. Os ratos receberam dietas líquidas contendo (&#946;-caroteno (24mg/L dieta) com (GAB) ou sem (GBC) a adição de etanol (36% da calorias totais da dieta) e dieta líquida normal (isenta de &#946;-caroteno e etanol) (GDN), durante seis semanas de período experimental. Após este período, os animais foram sacrificados para determinações hepáticas e plasmáticas de (&#946;-caroteno, retinol, palmitato de retinila, presença de esteatose, determinações hepáticas de SRATB e GSH, danos no DNA de hepatócitos e expressão do PCNA e da proteína p53. Os resultados mostraram diferenças (p<0,05) entre os grupos quanto as concentrações hepáticas de retinol (&#181;g/g) (GAB: 2,49 ± 0,25; GBC: 4,22 ± 0,24; GDN: 2,83 ± 0,21) e palmitato de retinila (&#181;g/g) (GAB: 40,87 ± 3,98; GBC: 83,72 ± 6,00; GDN: 46,33 ± 3,60), concentração plasmática de retinol (llmol/L) (GAB: 1,42 ± 0,12; GBC: 0,69 ± 0,06; GDN: 2,37 ± 0,28), presença de esteatose (GAB: 2,30 ± 0,21; GBC: 1,00 ± 0,00; GDN: 1,00 ± 0,00), danos no DNA de hepatócitos (danos DNA/100 hepatócitos) (GAB: 285,90 ± 15,20; GBC: 273,83 ± 13,39; GDN: 138,00 ± 4,04) e expressão do PCNA (%0) (GAB: 7,12 ± 1,46; GBC: 1,47 ± 0,27; GDN: 2,04 ± 0,31). As concentrações hepáticas e plasmáticas de &#946;-caroteno, SRATB e GSH hepáticos, não apresentaram diferença (p>0,05) entre os grupos. A proteína p53 não foi expressa em nenhum dos grupos estudados. Estes resultados mostraram que o (&#946;-caroteno isolado e em associação com o etanol não influenciaram na peroxidação lipídica e na expressão da proteína p53. A associação &#946;-caroteno + etanol foi mais prejudicial ao fígado, promovendo alterações no metabolismo celular dos hepatócitos, esteatose, danos no DNA e proliferação celular, considerando que o &#946;-caroteno isolado foi genotóxico ao hepatócito. / &#946;-carotene, when supplemented in smokers and alcohol drinkers may act as prooxidant, resulting in undesirable effects. The liver is the &#946;-carotene and vitamin A main storage organ and where ethanol oxidation takes place. This study investigated in rats\' liver, the influence of &#946;-carotene supplementation either alone or associated with ethanol in cellular metabolism, DNA damage, cellular proliferation and p53 protein function. Three groups of 12 rats received liquid diets containing &#946;-carotene (24mg/L diet) with (BAG) or without (CBG) ethanol (36% of total energy intake). Control animals received liquid diet free of ethanol and &#946;-carotene (NDG). After 6 weeks the animals were sacrificed for hepatic and plasma concentrations of &#946;-carotene, retinol, palmitate retinyl, steatosis, GSH and TBARS, DNA damage, PCNA and p53 expression were evaluated in the liver. Differences were significant for hepatic (BAG: 2.49 ± 0.25; CBG: 4.22 ± 0.24; NDG: 2.83 ± 0.21 mg/g) and plasmatic (BAG: 1.42 ± 0.12; CBG: 0.69 ± 0.06; NDG: 2,37 ± 0,28mmol/L) retinol and hepatic palmitate retinyl (BAG: 40.87 ± 3.98; CBG: 83.72 ± 6.00; NDG: 46.33 ± 3.60), steatosis (BAG: 2.30 ± 0.21; CBG: 1.00 ± 0.00; NDG: 1.00 ± 0.00), DNA damage (BAG: 285.90 ± 15.20; CBG: 273.83 ± 13.39; NDG: 138.00 ±4.04 DNA damages/100 hepatocytes) and PCNA expression (BAG: 7.12 ± 1.46; CBG: 1.47 ± 0.27; NDG: 2.04 ± 0.31) among the groups (p<0.05). Hepatic and plasmatic concentrations of &#946;carotene, TBARS and GSH were not statistically different. p53 staining was not detected in any group. This suggests that &#946;-carotene alone or with ethanol association does not influence lipid peroxidation and p53 expression. &#946;-carotene+ethanol caused metabolic alteration, steatosis, DNA damage and cellular proliferation in hepatocytes. Furthermore, supplementation with &#946;-carotene alone had genotoxic effects in the liver.

Chez les cellules humaines, environ 2 mètres d'ADN est compacté dans le noyau cellulaire par la formation d'une structure nucléoprotéique appelée chromatine. La chromatine est composée d'ADN enroulé à la surface d'un octamère de core histones pour former une structure appelée nucléosome. La structure de la chromatine doit être altérée afin d'accéder à l'information génétique pour sa réplication, sa réparation et sa transcription. La duplication de la chromatine lors de la phase S est cruciale pour la prolifération et la survie des cellules. Cette duplication de la chromatine requière une ségrégation des histones parentales, mais aussi une déposition d'histones néo-synthétisées sur l'ADN. Ces deux réactions résultent en formation de chromatine dès qu'une quantité suffisante d'ADNest générée par la machinerie de réplication. De plus, en raison de conditions intrinsèques et extrinsèques, la machinerie de réplication est souvent confrontée à de nombreux obstacles, sous la forme de lésions à l'ADN qui interfèrent avec la réplication de l'ADN. Sous ces conditions, l'assemblage de nucléosomes et la synthèse d'histones sont étroitement régulées afin d'éviter la production d'un excès d'histones et leurs nombreuses conséquences nuisibles à la cellule. "Chromatin Assembly Factor 1" (CAF-1) est responsable de la déposition initiale des molécules d'H3 et H4 derrière les fourches de réplication. Pour permettre sa fonction d'assemblage de chromatine, CAF-1 est localisée aux fourches de réplication en vertue de sa liaison à une protéine appelée Proliferating Cell Nuclear Antigen (PCNA). Cependant, le mécanisme moléculaire par lequel CAF-1 exerce sa function demeure mal compris. Dans le deuxième chapitre de ma thèse, j'ai exploré comment CAF-1 se lie à PCNA d'une manière distincte des nombreux autres partenaires de PCNA. Grâce à nos collaborateurs, des études de crystallographie ont démontré que CAF-1 se lie à PCNA grâce à une interaction non-canonique entre le "PCNA Interaction Peptide" (PIP) de CAF-1 et une interaction de type cation-pi (π). Nous avons aussi montré qu'une substitution d'un seul acide aminé, unique au PIP de CAF-1, abolit son interaction avec PCNA et sa capacité d'assemblage de nuclésomes. Nous avons aussi montré que le PIP de CAF-1 est situé à l'extrémité C-terminale d'une très longue hélice alpha qui est conservée à travers l'évolution parmi de nombreux homologues de CAF-1. Nos études biophysiques ontmontré que cette longue hélice alpha forme des structures oligomériques de type "coiled-coil", ce qui suggère certains mécanismes pour dédier un anneau de PCNA à l'assemblage de chromatine et ce, en dépit des nombreux intéracteurs de PCNA présents aux fourches de réplication. Dans le troisième chapitre de ma thèse, nos collaborateurs et moi-même avons étudié les mécanismes moléculaires par lesquels les cellules parviennent à maintenir un équilibre délicat entre la synthèse d'ADN et la synthèse d'histones et ce, même en présence de lésions à l'ADN qui interfèrent avec la réplication. Chez Saccharomyces cerevisiae, nous avons montré que les kinases de réponse au dommage à l'ADN, Mec1/Tel1 et Rad53, inhibent la transcription des gènes d'histones en réponse aux liaisons à l'ADN qui interfèrent avec la réplication. Nous avons montré que la répression des gènes d'histones induite par le dommage à l'ADN est médiée par une phosphorylation extensive de Hpc2, l'une des sous-unités du complexe "Histone Gene Repressor" (HIR). Hpc2 contient un domaine qui se lie à l'histone H3. À partir de la structure d'Hpc2, nous avons généré des mutants qui, d'après la structure, sont incapables de se lier à l'histone H3. Nos résultats montrent que l'accumulation d'histones en excès provoquée par le dommage à l'ADN entraîne la phosphorylation d'Hpc2 and la liaison de l'excès d'histone H3 à Hpc2. Ces résultats suggèrent que la répression transcriptionnelle des gènes d'histones induite par le dommage à l'ADN est médiée, du moins en partie, par une simple rétroaction négative impliquant la liaison des histones en excès à la sous-unité Hpc2 du complexe HIR. / In human cells, roughly 2 meters of DNA is compacted into the cell nucleus by the formation of a nucleoprotein complex called chromatin. Chromatin is composed of DNA wrapped around an octamer of core histones to form so-called nucleosomes. Chromatin structure needs to be altered to access genetic information for processes like replication, repair and transcription. Duplication of chromatin during S phase is vital for cell proliferation and viability. Chromatin duplication requires segregation of parental histones, but also deposition of newly synthesized histones onto DNA. This process results in packaging all of the synthesized DNA with histones to form nucleosomes as soon as enough nascent DNA has emerged from the replication machinery. Moreover, as a result of intrinsic and extrinsic conditions, the replication machinery often encounters DNA lesions that impede the continuous synthesis of DNA. Under these conditions, nucleosome assembly and histone synthesis are tightly regulated to prevent the production of an excess of histone proteins and their deleterious consequences. Chromatin Assembly Factor-1 (CAF-1) performs the initial step in chromatin assembly by depositing newly synthesized histone H3-H4 molecules behind replication forks. In order to perform its chromatin assembly function, CAF-1 localizes to DNA replication forks by binding directly to a protein known as the Proliferating Cell Nuclear Antigen (PCNA). However, the exact molecular mechanism by which this is achieved remains poorly understood. Through the second chapter of my thesis, I have explored how CAF-1 binds PCNA in a manner that is distinct from the numerous other binding partners of PCNA. With the help of our collaborators, crystallographic studies demonstrated that CAF-1 binds to PCNA by virtue of a non-canonical PCNA interaction peptide (PIP) and a cation-pi (π) interaction. We have also shown that a single amino acid substitution, unique to the PIP of CAF-1, disrupts its binding to PCNA and chromatin assembly activity. We found that the CAF-1 p150 PIP resides at the extreme C-terminus of a long alpha helix that is evolutionarily conserved among numerous homologues of CAF-1. Our biophysical studies showed that this long alpha-helix is capable of forming higher-order coiled coils, which suggests mechanisms to dedicate one PCNA ring for chromatin assembly despite the presence of multiple PCNA interactors at replication forks. In the third chapter of this thesis, our collaborators and I have addressed the crucial molecular mechanisms by which cells maintain a delicate balance between DNA and histone synthesis despite the presence of DNA lesions that interfere with replication. In Saccharomyces cerevisiae, we showed that the DNA damage response kinases Mec1/Tel1 and Rad53 inhibit histone gene transcription when DNA lesions block DNA replication. We also showed that this repression is mediated by phosphorylation of the Hpc2 subunit of the Histone Gene Repressor complex (HIR). Hpc2 contains a domain that directly binds to histone H3. Interestingly, structure-based mutants of Hpc2 predicted to be incapable of binding H3 are defective in DNA damage-induced transcriptional repression of histone genes in response to DNA damage during replication. Our results indicate that the accumulation of excess histones caused by DNA damage during S phase triggers extensive phosphorylation of Hpc2 and binding of excess H3 to Hpc2. This suggests that DNA damage-induced repression of histone genes is mediated, at least in part, by a simple negative feedback triggered by binding of excess histones to the Hpc2 subunit of the HIR complex.

Trinucleotide repeat (TNR) instability including repeat expansions and repeat deletions is the cause of more than 40 inherited incurable neurodegenerative diseases and cancer. TNR instability is associated with DNA damage and base excision repair (BER). In this dissertation research, we explored the mechanisms of BER-mediated TNR instability via biochemical analysis of the BER protein activities, DNA structures, protein-protein interaction, and protein-DNA interaction by reconstructing BER in vitro using synthesized oligonucleotide TNR substrates and purified human proteins. First, we evaluated a germline DNA polymerase β (pol β) polymorphic variant, pol βR137Q, in leading TNR instability-mediated cancers or neurodegenerative diseases. We find that the pol βR137Q has slightly weaker DNA synthesis activity compared to that of wild-type (WT) pol β. Because of the similar abilities between pol βR137Q and WT pol β in bypassing a template loop structure, both pol βR137Q and WT pol β induces similar amount of repeat deletion. We conclude that the slightly weaker DNA synthesis activity of pol βR137Q does not alter the TNR instability compared to that of WT pol β, suggesting that the pol βR137Q carriers do not have an altered risk in developing TNR instability-mediated human diseases. We then investigated the role of DNA synthesis activities of DNA polymerases in modulating TNR instability. We find that pol βY265C and pol ν with very weak DNA synthesis activities predominantly promote TNR deletions. We identify that the sequences of TNRs may also affect DNA synthesis and alter the outcomes of TNR instability. By inhibiting the DNA synthesis activity of pol β using a pol β inhibitor, we find that the outcome of TNR instability is shifted toward repeat deletions. The results provide the direct evidence that DNA synthesis activity of DNA polymerases can be utilized as a potential therapeutic target for treating TNR expansion diseases. Finally, we explored the role of post-translational modification (PTM) of proliferating cell nuclear antigen (PCNA) on TNR instability. We find that ubiquitinated PCNA (ub-PCNA) stimulates Fanconi associated nuclease 1 (FAN1) 5’-3’ exonucleolytic activities directly on hairpin structures, coordinating flap endonuclease 1 (FEN1) in removing difficult secondary structures, thereby suppressing TNR expansions. The results suggest a role of mono-ubiquitination of PCNA in maintaining TNR stability by regulating nucleases switching. Our results suggest enzymatic activities of DNA polymerases and nucleases and the regulation of the activities by PTM play important roles in BER-mediated TNR instability. This research provides the molecular basis for future development of new therapeutic strategies for prevention and treatment of TNR-mediated neurodegenerative diseases.

Epidemiological, experimental, and clinical observations provide support for a colorectal cancer chemopreventive role for aspirin. We have evaluated the effects of aspirin on proliferation biomarkers in normal-risk and high-risk human subjects for colorectal cancer. Colorectal biopsies were obtained at baseline and at 24h after 28 daily doses of 81mg of aspirin from 13 high-risk and 15 normal-risk subjects for colorectal cancer. We evaluated aspirin's effects on proliferating cell nuclear antigen (PCNA) immunohistochemistry and epithelial mucin histochemistry using the lectin, Amaranthus caudatus agglutinin (ACA) in crypt sections from rectal biopsies. The baseline whole crypt PCNA LIs differed significantly between normal-risk and high-risk subjects. PCNA LIs are not affected by 28 days of aspirin at 81mg daily. ACA LIs are decreased by 28 days of aspirin at 81mg daily in both normal-risk and high-risk subjects. Aspirin's effects on ACA LIs may have mechanistic and biological implications that deserve further attention. PCNA and ACA LIs are not useful as proliferation biomarkers for aspirin's chemopreventive activity in morphologically normal human colorectal mucosa.

No description available.

No description available.